HSCI Principal Faculty member Jose Ordovas-Montanes has received an early-career award from the New York Stem Cell Foundation (NYSCF). He has been named a NYSCF – Robertson Investigator, which recognizes cutting-edge research with the potential to accelerate treatments and cures. The award provides seed funding of $1.5 million over five years to enable...
Mario Suva and Ramesh Shivdasani are tackling some of the toughest, meanest cancers to clear a path to better treatments.
Suva and Shivdasani are using every approach in their arsenal to figure out what makes cancer cells arise from healthy tissue.
Armed with enough new knowledge about how cancer arises, they want to take truer aim at cancer cells, the cancer cell lineage, and factors that make cells go awry.
Their new approach to cancer management would combine gene and cell therapies to kill the cancer...
Advances in engineering blood cells, treating diabetes, regenerating joints, and growing organs
On May 31, 2018, Harvard Stem Cell Institute (HSCI) faculty members shared their research updates at the Harvard Medical School (HMS) Alumni Reunion symposium. Their work showcased the breadth of research being conducted across the HSCI network, both at Harvard University and its...